(Q53636461)

16 May 2018

title

Donor cytomegalovirus seropositivity and the risk of leukemic relapse after reduced-intensity transplants. (English)

1 reference

16 May 2018

0 references

1 reference

David Nachbaur

1

1 reference

16 May 2018

Johannes Clausen

series ordinal

2

1 reference

16 May 2018

Brigitte Kircher

series ordinal

3

1 reference

16 May 2018

publication date

15 February 2006

1 reference

16 May 2018

European Journal of Haematology

published in

1 reference

16 May 2018

volume

76

1 reference

16 May 2018

issue

5

1 reference

16 May 2018

page(s)

414-419

1 reference

16 May 2018

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

Stem cell transplantation for chronic myeloid leukemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

Donor CMV serologic status and outcome of CMV-seropositive recipients after unrelated donor stem cell transplantation: an EBMT megafile analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2005.00625.X

10.1111/J.1600-0609.2005.00625.X

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

1 reference

16 May 2018